Skip to main content
VCbacked
Log inGet Started

Slingshot Biosciences

Emeryville, United States

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

$15.0M raised
Apr 2024
Series A
BiotechnologyMedicalTherapeutics

Top Investors

ARCH Venture PartnersAnterra CapitalNorthpond VenturesTao Capital PartnersImpactAssets

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Slingshot Biosciences

How much funding has Slingshot Biosciences raised?
Slingshot Biosciences has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Who are Slingshot Biosciences's investors?
Slingshot Biosciences's investors include ARCH Venture Partners, Anterra Capital, Northpond Ventures, Tao Capital Partners, ImpactAssets.
Where is Slingshot Biosciences headquartered?
Slingshot Biosciences is headquartered in Emeryville, United States.
What does Slingshot Biosciences do?
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
What stage is Slingshot Biosciences at?
Slingshot Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Slingshot Biosciences — Funding & Investors." VCBacked, April 26, 2024, https://www.vcbacked.co/company/slingshot-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2024). Slingshot Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/slingshot-biosciences
Wikipedia (cite web)
{{cite web |title=Slingshot Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/slingshot-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong